← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phoenix Pharmacologics, Inc.
Lexington, KY
$1,743,473
Total funding
4
Grants
Funding mix
By agency
NIH$1,743,473 · 4
By mechanism
R44$1,543,511 · 2
R43$199,962 · 2
Investigators at Phoenix Pharmacologics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Development of PEG-TNF$407,578
R44 · FY2005 · CA
Preclinical Development of PEG-TNF$401,250
R44 · FY2004 · CA
Arginine deiminase as an Anti-Cancer Therapy$383,600
R44 · FY2001 · CA
Arginine deiminase as an Anti-Cancer Therapy$351,083
R44 · FY2002 · CA
Preclinical Development of Uricase-PEG 20$100,000
R43 · FY2002 · DK
MODIFIED TNF-ALPHA: AN ANTI CANCER THERAPY$99,962
R43 · FY2001 · CA